Jun 22, 2020
Lantheus Completes Merger with Progenics
Jun 22, 2020
Intranasal immunization With Intravacc's Experimental Whooping Cough Vaccine Confers Broad Protection
Jun 22, 2020
Therapeutic Use of CBD Continues to Spread
Jun 22, 2020
InventHelp Inventor Develops Human Brain Model for Psychiatrists (PND-5039)
Jun 22, 2020
FDA In Brief: FDA Launches New Export Certification Application System for Animal Products
Jun 19, 2020
TBRC Reports: Production of New Insulin Biosimilars is The Latest Trend in The Market, as Seen With Biocon's Newly FDA Approved Semglee
Jun 18, 2020
Biocomposites Announces STIMULAN® Products Added to NHS Supply Chain
Jun 18, 2020
Worldwide DNA Vaccine Market (2020 to 2022) - Increasing Focus on Genetic Vaccine Development
Jun 18, 2020
Linnaeus Therapeutics Granted U.S. FDA Fast Track Designation for LNS8801 for the Treatment of Patients with Metastatic or Unresectable Melanoma Who Have Progressed on Anti-PD-1/L1 Therapy
Jun 18, 2020
Global Endometriosis Market and Competitive Landscape to 2024
Jun 18, 2020
Worldwide Human Papillomavirus (HPV) Vaccines Overview 2020 - Pipeline & Marketed Vaccines, Regulatory Events, Clinical Trial Landscape, Future Trends, KOL Insights, Unmet Needs, Sales (2015-2024)
Jun 17, 2020
Perrigo Partners With Kazmira LLC To Enter CBD Market Through A Two-Phased, Science-Based Approach
Jun 17, 2020
Race For Vaccine Intensifies As COVID-19 Second Wave of Outbreaks Threatens
Jun 17, 2020
Salicylic Acid Market to Garner $490.8 Million, Globally, By 2027 at 8.0% CAGR, Says Allied Market Research
Jun 16, 2020
Verzenio® (abemaciclib) Significantly Reduced the Risk of Cancer Returning in People with High Risk HR+, HER2- Early Breast Cancer
Jun 16, 2020
Biohaven Presents NURTEC(TM) (rimegepant) Clinical and Pharmacoeconomic Data at the American Headache Society (AHS) Virtual Annual Scientific Meeting
Jun 15, 2020
AbbVie to Showcase 27 Studies at the Virtual 2020 Annual Scientific Meeting of the American Headache Society
Jun 13, 2020
EHA25Virtual: Study of Subcutaneous Daratumumab Shows Improved Clinical Outcomes in the Treatment of Patients with Amyloidosis
Jun 13, 2020
Halozyme Announces Findings From Janssen's Phase 3 Andromeda Study Evaluating Subcutaneous Daratumumab Utilizing ENHANZE® In Light-Chain Amyloidosis Presented At European Hematology Association 25th Annual Congress
Jun 12, 2020
EHA25Virtual: Promising Treatment Results with Imetelstat, a Novel Telomerase Inhibitor, in Patients with Lower Risk Myelodysplastic Syndromes